A new study has demonstrated the potential of excitatory intermittent theta burst stimulation (iTBS) for reducing spasticity in patients with spinal cord injury.
Investigators hope that their findings will assist in the development of targeted treatments for pediatric brain cancers.
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
An international research team have shown that gene editing reverses Huntington’s symptoms without off-target effects in a mouse model.
Anthranilic acid is associated with greater risk of dementia, along with other kynurenine pathway metabolites.
Researchers discover that the drug, pyrimethamine, may reduce disease progression in patients with inherited amyotrophic lateral sclerosis (ALS).
Today at Neuro Central and Future Science Group, we’re celebrating Alzheimer’s Society’s #CupcakeDay; a national campaign to raise vital funds for dementia research by baking, selling and eating cupcakes!
Researchers from the University of Central Florida hope to use the CRISPR Cas9 method to screen drugs for Parkinson’s disease.
A large-scale, population-based study has demonstrated a relationship between persistent pain and cognitive decline.